Assorted News from the Last Week:
Researchers advance fertility options for childhood cancer survivors.
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.
Major EU study to investigate the role of environmental factors in childhood cancer.
What adolescents and young adults with cancer want researchers to know.
Upcoming Webinars, Online Opportunities, and Meetings:
Following the cancellation of the 2025 Childhood Cancer Data Initiative (CCDI) Symposium originally scheduled for last fall, NCI will inaugurate the CCDI Virtual Symposium Series in the coming weeks. Sessions will occur across multiple days in March and April. Click Here to Learn More and Register.
CCDI Virtual Symposium: CAR-NKT Cell Therapy for Neuroblastoma on July 14, 2026, from 1:00–2:00 p.m. ET. Click here to register.
The 58th Annual Congress of the International Society of Paediatric Oncology (SIOP 2026) September 15-18 in San Antonio, Texas & Online. For information and to register.
CCDI Symposium on September 17-18, hosted by the National Cancer Institute, has opened registration. Click for more information and to register.
15th GOLDEN TOAST 2026, September 17 at 6:00 ET. Click for more information.
CureFest registration now open! September 18-20. Click for more information and to register.
Recent Recordings:
Children’s Cancer Cause joined Cancer Nation and the Lymphoma Research Foundation on June 15th for Right to Thrive: A Conversation on the Lainie Jones Comprehensive Cancer Survivorship Act (CCSA), a virtual town hall focused on newly introduced bipartisan legislation to advance survivorship care.
Take Action:
On behalf of CCI Europe, childhood cancer survivors (with a cancer diagnosis before or until 18 years of age)are invited to complete a survey being conducted as part of the PhD project “SurNet: Addressing the Psychosocial Needs of Survivors of Pediatric Cancer” at Iscte – Instituto Universitário de Lisboa. Please submit responses before July 31.
On behalf of ACCELERATE, you’re invited to submit your expression of interest in participating at the 16th ACCELERATE Paediatric Strategy Forum, taking place in Paris, France on 29 and 30 October 2026. The meeting aims include:
- Clearly ascertain the role of targeting B7H3 in paediatric cancer
- Identify which of the many types of inhibitors are of highest value for
children and adolescents - Identify the relevant malignancies with unmet medical needs
- Facilitate prioritisation of assets for the treatment of paediatric
malignancies
Click here to learn more and submit an Expression of Interest.
SUBSCRIBE
Sign up to receive a copy of CAC2’s free childhood cancer news digest in your inbox each week.